SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Replimune Group Inc. has entered into an underwriting agreement to sell an aggregate of 9,701,490 shares of common stock and pre-funded warrants for 2...
Phase 2 trial of ABCL635 met primary endpoints for hot flash reduction. The results mark a new efficacy benchmark for the treatment of vasomotor sympt...
Institutional holdings report (13F-HR) filed by Lightrock Netherlands B.V.....
Athene Holding Ltd. released its unaudited financial results for 2022, including detailed non-GAAP measures regarding net investment earnings, net flo...
Aeries Technology reported strong quarterly results with revenue rising 43% and profit and operating cash flow more than tripling. The company reaffir...
Institutional holdings report (13F-HR) filed by Munro Partners....
Sharplink reported Q2 2026 revenue increased to $11.5 million from $0.7 million, driven by its正式启动的ETH treasury strategy, supported by notable Ethereu...
Institutional holdings report (13F-HR) filed by Ironvine Capital Partners, LLC....
Jazz Pharmaceuticals announced a definitive agreement to acquire Actio Biosciences for $820 million upfront to acquire ABS-1230, a potential precision...
Sonida Senior Living (SNDA) reported increased occupancy and funds from operations for Q2 2026 while finalizing a $372.5 million amended term loan agr...
Institutional holdings report (13F-HR) filed by ALLIANZ SE....
L.B. Foster reported record second quarter operating cash flow, reduced total debt by 41.2%, and reaffirmed its full year 2026 sales and adjusted EBIT...
GCM Grosvenor reported second quarter 2026 earnings with GAAP net income of $9.6 million and adjusted net income up 22% year-over-year. The firm also ...
Varex Imaging Corp reported Q3 FY26 revenue of $211 million and non-GAAP EPS of $0.31. The company announced the cancellation of its earnings conferen...
The company reported a record $295 million net income for Q2 2026 and announced the largest quarterly dividend in its history, supported by strong liq...
The company reported cash and equivalents of $72.1 million and a decrease in R&D expenses for Q2 2026, driven by completion of zerlasiran Phase 3 read...
Apogee Therapeutics agreed to be acquired by AbbVie for approximately $10.9 billion while also reporting Q2 2026 financial results and positive Phase ...
Institutional holdings report (13F-HR) filed by BLI - Banque de Luxembourg Investments....
Liberty Media announced a proposed private offering of $600M in convertible senior notes with an option for an additional $90M. Net proceeds will be u...
Tenax Therapeutics reports that its Phase 3 LEVEL study for TNX-103 did not meet its primary endpoint, though exploratory analysis showed reduced NT-p...